EPG Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

EPG Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,999	Closed	-$138K	–	221
2022 Q1	$138K	Sell	2,999 -1,480	-33%	-$70.6K	0.05%	247
2021 Q4	$274K	Sell	4,479 -14,205	-76%	-$982K	0.1%	181
2021 Q3	$1.4M	Sell	18,684 -1,734	-8%	-$145K	0.56%	38
2021 Q2	$1.89M	Sell	20,418 -6,385	-24%	-$543K	0.8%	26
2021 Q1	$2.38M	Sell	26,803 -2,551	-9%	-$253K	1.16%	19
2020 Q4	$2.74M	Buy	29,354 +3,780	+15%	+$301K	1.64%	12
2020 Q3	$1.63M	Buy	25,574 +103	+0.4%	+$6.04K	1.2%	19
2020 Q2	$1.33M	Buy	25,471 +21,980	+630%	+$943K	0.94%	25
2020 Q1	$109K	Buy	+3,491	New	+$117K	0.08%	164

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

EPG Wealth Management's ARKG Position: Q2 2022 in Review

EPG Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 2,999 shares — an estimated $138K sold.

EPG Wealth Management first reported a position in ARKG in Q1 2020 and held it in 9 quarters. The position peaked at $2.74M in Q4 2020. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

EPG Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
EPG Wealth Management sold 2,999 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $138K.
EPG Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2020 and held it in 9 quarters.
EPG Wealth Management's ARK Genomic Revolution ETF position peaked at $2.74M in Q4 2020.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on EPG Wealth Management's 13F filing for Q2 2022, filed 15 Aug 2022.